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Abstract
Background: The glaucoma-specific blindness prevalence in Nigeria (0.7 %, 95 % CI 0.6–0.9 %) among those aged
≥40 years is one of the highest ever reported. This study determined the risk factors for open-angle glaucoma
(OAG) in adults examined in the Nigeria National Blindness and Visual Impairment Survey.
Methods: A nationally representative sample of 13,591 people aged ≥40 years in 305 clusters in Nigeria were examined
(response rate 90.4 %) between January 2005 to June 2007. Everyone had logMAR visual acuity measurement, Frequency
Doubling Technology (FDT) visual field testing, autorefraction, A-scan biometry and optic disc assessment. Full ocular
examination (n = 6397), included Goldmann applanation tonometry. Values for defining glaucoma using International
Society of Geographical and Epidemiological Ophthalmology criteria were derived from the study population.
Disc images were graded by Moorfields Eye Hospital Reading Centre. Socio-demographic factors (age, gender,
ethnicity, literacy and place of residence), ocular parameters (intraocular pressure [IOP], axial length and mean
ocular perfusion pressure [MOPP]) and systemic parameters (blood pressure, blood glucose and body mass index
[BMI]) were assessed for association with OAG.
Results: Thirteen thousand eighty-one (96 %) of 13,591 participants had vertical cup:disc ratio measured in at least one
eye. 682 eyes of 462 participants were classified as OAG, with 12,738 controls. In univariate analyses the following were
associated with OAG: increasing age, male gender, Igbo and Yoruba ethnic groups, illiteracy, longer axial length, higher
IOP, lower MOPP, greater severity of hypertension and low BMI (underweight). In multivariate analysis, increasing age
(odds ratio [OR] 1.04, 95 % CI 1.03–1.05), higher IOP (OR 1.22, 95 % CI 1.18–1.25) and Igbo ethnicity (OR 1.73,
95 % CI 1.18–2.56) were independent risk factors for OAG.
Conclusion: Case detection strategies for OAG should be improved for those aged ≥40 years and for ethnic groups
most at risk as a public health intervention.
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Background
In 2013 it was estimated that there were 64.3 million
people aged 40–80 years with glaucoma worldwide, pro-
jected to increase to 76.0 million by the year 2020 and
111.8 million in 2040 [1]. Open-angle glaucoma (OAG)
is the most prevalent type of glaucoma in Africa [1–6]
and a leading cause of blindness and visual impairment
[2, 7]. The glaucoma-specific blindness prevalence in
Nigeria (0.7 %, 95 % confidence interval [CI] 0.6–0.9 %)
among those aged 40 years and above is one of the highest
ever reported [8], and glaucoma is the second-leading
cause of blindness after cataract [8]. The all glaucoma
prevalence in Nigeria in this age-group was 5.02 % (95 %
CI 4.60–5.47 %), with 86 % being OAG based on gonio-
scopy. An estimated 1.2 million adults in Nigeria had
glaucoma in 2012 [9].
There are some similarities in the epidemiology of
OAG in sub-Saharan African and Caribbean popula-
tions. An interesting aspect of the Barbadian history is
that a significant portion of the population was derived
from the Bight of Biafra (also known as Bight of Bonny)
in southeastern Nigeria; and about 44 % of enslaved
Africans taken to Barbados during the 18th century were
said to be mainly of Igbo origin [10]. Studies of risk
factors for OAG in sub-Saharan Africa and African-
derived black populations have reported that increasing
age [3–6, 11–13] and higher intra-ocular pressures
(IOP) [3, 4, 12, 14] are consistent and important risk fac-
tors. Although not always observed, men have a higher
prevalence of glaucoma [4, 5, 12, 15]. A consistent find-
ing is a higher prevalence of OAG in blacks compared
to whites in populations where the two racial groups
were studied [11, 13, 15]. The prevalence of glaucoma
was higher in those with darker skin and of African birth
[13], which suggest possible influence of environmental
factors and inter-ethnic variation in the prevalence and
risk of OAG within black populations, mediated by gen-
etic factors. A higher prevalence of OAG in the urban
population of Chennai compared to the rural population
suggest a possible influence of lifestyle differences and
non-communicable diseases such as hypertension and
diabetes which are also more prevalent in the urban
population [16]. Very few studies have explored other
socio-demographic and systemic risk factors.
The Nigeria National Blindness and Visual Impair-
ment Survey (hereafter referred to as the Nigeria Blind-
ness Survey) is one of the largest population-based
survey ever undertaken in Africa [17]. The present paper
analysed data from the Nigeria Blindness Survey to ex-
plore risk factors for OAG among adults aged ≥40 years.
Factors other than age and IOP were assessed. Identify-
ing population groups most at risk, such as ethnic
groups, will aid in planning appropriate control strat-
egies and enhance the development of care-pathways to
prevent visual loss from glaucoma. It is envisaged that
these results will also be relevant to other countries in
sub-Saharan Africa and for African-derived black
populations.
Methods
Details of all the methods used in the Nigeria Blindness
Survey have been published [17] as well as data on the
prevalence [7] and causes of visual impairment and
blindness [8] and the prevalence and types of glaucoma
in Nigeria [9].
Study design
The sample size calculation and sampling strategy for
the Nigeria Blindness Survey gave a nationally represen-
tative sample of 15,375 persons aged 40 years and above
in 310 clusters across the country. The sample size was
also adequate for precise estimates of glaucoma preva-
lence and was adequately powered for risk factor ana-
lysis for OAG.
Multi-stage sampling using probability proportional to
size methods was used to select the study population.
Clinical data were collected by two teams, each compris-
ing two ophthalmologists, one optometrist and two
ophthalmic nurses.
Data collection
All participants were invited to a temporary clinic for
examination. Relevant personal and demographic details
and examination findings were recorded.
The examination flow chart (Fig. 1; adapted [17]) indi-
cates the data collected by the team members. All partic-
ipants had presenting and best-corrected visual acuity
(VA) measured with a reduced logMAR tumbling E-
chart, automated refraction and keratometry (Takagi
ARKM-100, Takagi Seiko, Japan), frequency doubling
technology (FDT) visual function testing (Carl Zeiss
Meditec AG Jena Germany) and ultrasound A-scan
biometry (Bioline Biometer OPTIKON 2000 S.p.A
Roma, Italy). All participants had basic eye examination
performed by the first ophthalmologist, and detailed
ocular examination was performed by the second oph-
thalmologist: in those with VA of worse than 20/40 in
one or both eyes; vertical cup:disc ratio (VCDR) ≥0.6 in
one or both eyes or VCDR asymmetry of ≥0.2, or any
retinal abnormality seen on undilated fundoscopy [17].
In addition, a subsample of 1-in-7 participants who also
had the detailed examination regardless of their VA had
a random blood glucose (RBG) test (OneTouch Ultra
blood glucose meter, LifeScan UK).
Risk factors assessment and classification
There were five socio-demographic ‘person’ factors (age,
gender, ethnic group, literacy and place of residence), six
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biophysical ‘person’ factors (presence of hypertension,
severity of hypertension, systolic blood pressure [SBP],
diastolic blood pressure [DBP], RBG and body mass
index [BMI]); and three ‘ocular’ factors (axial length,
IOP and mean ocular perfusion pressure [MOPP]). Age
was analysed as a continuous variable and gender as
a binary variable. Participants were asked about their
ability to read and/or write and their ethnic group.
Literacy was classified as ability to read and write or
not at all and analysed as a binary variable. The geo-
graphical origins of some of the major ethnic groups
are shown in Fig. 2. The Ibibio and Ijaw are from the
southern Niger delta region, the Igbos and Urhobos
are from the southeastern equatorial region and the
Hausa, Fulani and Kanuri are from the northern
savannah region. Ethnic groups with ≥200 participants
(Hausa, Yoruba, Igbo, Fulani, Kanuri, Tiv, Ijaw,
Urhobo, Ibibio and Nupe) were categorised and ana-
lysed separately, and the smaller ethnic groups were
combined into an ‘others’ category. Urban place of
residence was defined as a settlement of more than
20,000 people.
Fig. 1 The Nigeria Blindness Survey examination flow chart
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Blood pressure (BP) was recorded three times with BP
Omron wrist instrument (Omron Healthcare Ltd, Milton
Keynes, England) after resting for at least 10 min [18].
Average values were used for analysis. Hypertension was
defined as BP ≥140/90 mmHg and severity was
categorised using World Health Organization (WHO)
categories: stage 1 for systolic/diastolic BP of ≥140/
90 mmHg, stage 2 ≥ 160/100 mmHg and stage 3 ≥ 180/
110 mmHg [19]. SBP and DBP were analysed as con-
tinuous variables. RBG was grouped as less than
11.1 mmol/L or ≥11.1 mmol/L [20]. Height was mea-
sured to the nearest tenth of a centimeter and weight
was measured to the nearest 100 g using standard equip-
ment. BMI was calculated by dividing body weight (kg)
by height (m) squared and categorised according to the
international classification for adults i.e., underweight
(<18.5 kg/m2), normal (18.5–24.9 kg/m2), overweight
(25.0–29.9 kg/m2) and obese (≥30.0 kg/m2) [21].
Axial length was measured by contact ultrasound A-
scan biometry. IOP was measured using one Goldmann
applanation tonometer in each of the two teams by the
second ophthalmologist, using standard methods. To ex-
plore the association of vascular perfusion and OAG,
the MOPP was calculated as 2/3[DBP +
1/3 (SBP-DBP)-
IOP] [22]. Axial length, IOP and MOPP were analysed
as continuous variables.
A person was classified as having glaucoma if one or
both eyes had glaucoma. The diagnosis of glaucoma was
based on the International Society for Geographical and
Epidemiological Ophthalmology (ISGEO) criteria with
defining values obtained from a subsample of this study
population [23]: VCDR ≥0.7 or VCDR asymmetry ≥0.1
Fig. 2 Geographical origins of ethnic groups and their open-angle glaucoma prevalence. Adapted from Map of the ethno-linguistic groups of
Nigeria. Source: University of Texas Libraries; obtained from https://commons.wikimedia.org/wiki/File:Nigeria_linguistic_1979.jpg
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(97.5th percentile) with evidence of glaucomatous visual
function deficit; or VCDR ≥0.75 or VCDR asymmetry
≥0.2 (99.5th percentile) when visual fields results were
not available; or IOP ≥28 mmHg (99.5th percentile) ± VA
worse than 20/400 or known glaucoma on treatment; or
if there was relative afferent pupillary defect (RAPD) as-
sociated with high IOP and/or corneal edema. The Van
Herick’s anterior chamber (AC) angle estimation was
performed on the slit-lamp with a narrow slit of light
projected on the peripheral cornea, and was based on
the relationship between the corneal slit image on the
corneal surface and the AC depth. Grades 3 and 4 infer
open angles and angle-closure is unlikely. The validity of
the Van Herick’s method for the estimation of the AC
angle to correctly identify grades 3–4 as being open an-
gles was assessed in comparison to identification of open
angles by gonioscopy. Eyes with glaucoma were classified
as OAG based on open-angles seen on gonioscopy or
Van Herick’s grades 3–4 in those who did not have
gonioscopy.
Data for all participants classified as OAG were com-
pared to those of the control group in analysis. Socio-
demographic, ocular and biophysical factors were analysed
for associations with OAG. The control group consisted
of all other participants without OAG after excluding
glaucoma eyes that did not have gonioscopy or Van Her-
ick’s test findings and those with other types of glaucoma,
and phthisical eyes. The algorithm for selection of OAG
cases and the control group is shown in Fig. 1.
Statistical analysis was performed using Stata/IC 13.0
(Stata Corp, College Station, TX).
We examined the association between OAG and each
risk factor separately and report odds ratios with 95 %
confidence intervals (CI). We used logistic regression to
assess the independent effect of each risk factor on OAG
and report adjusted odds ratios and 95 % CI intervals.
BMI was also adjusted for gender. The following vari-
ables were included in the multivariable model: age, gen-
der, ethnic group, literacy, rural/urban residence, BP,
BMI, ocular axial length, IOP and MOPP. For ocular
factors, the analysis took account of within-person
correlation using robust standard errors. Possible extra
variation introduced by the cluster sampling strategy
was also considered but it did not impact the results.
Results
A summary of completeness of data for the Nigeria
Blindness Survey has been reported: for participants
undergoing full examination (6397), 88 % had IOP meas-
urement with Goldmann applanation tonometer in at
least one eye [9]. In the Nigeria Blindness Survey, 950/
27,182 (3.50 %) eyes of 682/13,591 (5.02 %) participants
had glaucoma according to the ISGEO criteria, of which
320 eyes of 208 persons were classified as OAG by
gonioscopy. 375 eyes had Van Herick’s AC angle estima-
tion but did not undergo gonioscopy. In eyes with both
values, Grades 3 and 4 Van Herick’s AC angle estimation
had a 99.1 % sensitivity and 93 % positive predictive
value in identifying open angles by gonioscopy. Thus, an
additional 362 eyes of 254 persons were included as
OAG cases as they had grades 3 or 4 Van Herick’s
estimation. Hence, 462 persons (682 eyes with OAG)
were included in the analysis as OAG while 12,738 per-
sons were classified as controls (without OAG) and 391
participants were excluded (Fig. 3).
The OAG group was older and more likely to be male
(Table 1). The mean age ± standard deviation (SD) of par-
ticipants with OAG was significantly higher than that of
controls (66.2 ± 12.3 years Vs 55.4 ± 12.1 years, p <0.001).
Men with OAG were significantly older (mean age
67.6 years ±12.7) than women with OAG (mean age
64.8 years ±11.8; p = 0.02). The OAG group also had a
higher proportion of participants that were of the Yoruba
or Igbo ethnic group, illiterate and with hypertension and
low BMI (underweight). After adjusting BMI for gender,
the odds of OAG was higher in underweight women (OR
1.84, 95%CI 1.27–2.68; p = 0.001) but not after adjusting
for age or for age and IOP. The mean ± SD IOP was
higher in eyes with OAG (22 ± 11 mmHg) than in eyes
without OAG (14 ± 4 mmHg, p <0.001). Similarly, the
mean ocular axial length was longer in eyes with OAG
(22.8 ± 1.09 mm) than in those without OAG (22.6 ±
0.97 mm, p = 0.001).
In univariate analysis, increasing age was positively as-
sociated with OAG (Odds ratio [OR] 1.06, 95 % CI
1.06–1.07; p <0.001), as was being male (OR 1.29, 95 %
CI 1.06–1.57; p = 0.01) (Table 2). There was 6 % higher
odds of OAG with each increasing year of age. The
following factors were also positively associated with
OAG: Igbo and Yoruba ethnic groups, being illiterate,
any hypertension and greater severity of hypertension,
low BMI (underweight), longer ocular axial length,
higher IOP and lower MOPP (Table 2). When adjusted
for myopia, axial length remained significantly associated
with OAG (OR 1.13, 95 % CI 1.02–1.25; p = 0.03). In
multivariate logistic regression analyses, increasing age,
higher IOP and Igbo ethnic group were identified as in-
dependent risk factors for OAG. The ethnic group-
specific prevalence of OAG for the analysed ethnic
groups are shown in Fig. 2. The Urhobo had the lowest
odds of OAG (OR 0.69, 95 % CI 0.24–1.97), while the
Kanuri (OR 1.81, 95 % CI 0.90–3.63; p = 0.10) and Igbo
(OR 1.73, 95 % CI 1.18–2.56; p = 0.01), the highest. The
Igbo ethnic group had a 73 % higher odds of OAG
than the Hausa (reference group) (Table 2); and when
adjusted for gender, Igbo men were 2.5 times more
likely to have OAG than Hausa men (OR 2.54, 95 %
CI 1,50–4.30; p = 0.001).
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Systemic hypertension (BP ≥ 140/90 mmHg) was
also associated with OAG, with moderate and severe
hypertension having stronger and significant associ-
ation with OAG in univariate analysis. After adjusting
for age, IOP and other potential risk factors in a mul-
tivariable model, mildly elevated BP (stage 1) was
protective of OAG compared to participants without
hypertension but this was not statistically significant
(OR 0.87, p = 0.52). There was a strong association
between lower MOPP and OAG (p <0.001) in univari-
ate analysis which did not persist after adjusting for
age, IOP and other factors.
In univariate analysis, lower BMI was associated
with 60 % greater odds of OAG (p = 0.001) and the
odds decreased with increasing BMI. However, in the
adjusted model, BMI was not statistically significant.
Discussion
We report results of the first cross-sectional study of
risk factors for OAG in sub-Saharan Africa in a large
population-based, nationally representative survey in
Nigeria. We did not explore the risk factors for angle-
closure glaucoma, as the numbers were too few. Older
age and higher IOP were independent risk factors for
OAG. Additionally, an important and new finding was
that the Igbo ethnicity was an independent risk factor
associated with OAG, especially in men.
Significant inter-racial variation between White, Asian
and Black populations has been described [11, 13, 15, 24]
with the prevalence and risks of OAG being higher in
Blacks. However, studies in smaller population groups
in sub-Saharan Africa have not identified differences
in risks of OAG by ethnic group within black popula-
tions [5, 25]. Under-powered sample sizes may be a
reason why they could not detect ethnic differences
in those studies. The Nigeria Blindness Survey had
relatively large numbers of the main ethnic groups,
giving adequate power to detect significant associa-
tions and differences within the black population.
One of the potential reasons for the ethnic
differences we observed may be the differential sus-
ceptibility due to larger optic discs. As reported in
the normative data for the classification of glaucoma
in prevalence surveys in Nigeria, the 97.5th percentile
VCDR for the Igbo was 0.7 compared to 0.6 for the
Fulani. Interestingly, the 99.5th percentile for IOP was
Fig. 3 Algorithm for selection of open-angle glaucoma cases and control
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Table 1 Distribution of participants with and without open-angle glaucoma by socio-demographic, biophysical and ocular
characteristics
Without OAG
[control]
OAG
[cases]
Total participants N = 12,946 n = 12,738 (96.5 %) n = 462 (3.5 %)
n % n %
Socio-demographic factors
Age group (years)
40 – 49 4760 37.4 45 9.7
50 – 59 3415 26.8 75 16.2
60 – 69 2550 20.0 124 26.9
70 – 79 1439 11.3 141 30.5
80+ 574 4.5 77 16.7
Age (years) Mean ± SD 55.4 ± 12.1 66.2 ± 12.3 p < 0.001
Gender
Female 6940 54.5 221 47.8
Male 5798 45.5 241 52.2
Ethnic groupa
Hausa 3191 25.2 78 16.9
Yoruba 2478 19.5 95 20.6
Igbo 1752 13.8 114 24.7
Fulani 801 6.3 20 4.3
Kanuri 326 2.6 13 2.8
Tiv 328 2.6 10 2.2
Ijaw 234 1.8 11 2.4
Urhobo 231 1.8 5 1.1
Ibibio 199 1.6 7 1.5
Nupe 198 1.6 8 1.8
Others 2946 23.2 100 21.7
Literacy
Literate 5618 44.1 159 34.4
Illiterate 7120 55.9 303 65.6
Place of residence
Rural 9883 77.6 354 76.6
Urban 2855 22.4 108 23.4
Biophysical factors
Blood pressure (mmHg)a
Normal 9343 73.8 308 67.2
Hypertension ≥140/90 mmHg 3315 26.2 150 32.8
Random blood glucose (mmol/L)a
Normal 1551 97.1 98 96.1
Diabetes ≥11.1 mmol/L 47 2.9 4 3.9
Body mass indexa
Normal 18.5–24.9 kg/m2 7672 61.1 276 60.6
Underweight <18.5 kg/m2 1365 10.9 74 16.3
Overweight 25.0–29.9 kg/m2 2464 19.6 75 16.5
Obese ≥30.0 kg/m2 1060 8.4 30 6.6
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lower for the Igbo (22 mmHg) than for the Hausa
(28 mmHg) [23] and this may imply that the Igbos
have thinner corneas. However, a major limitation in
interpreting this difference is the absence of pach-
ymetry to measure central corneal thickness in the
Nigeria Blindness Survey, which would have enabled
corrected IOP estimates for comparison. Optic disc
parameters are important in OAG with respect to at-
tenuation of structural support, axonal protection and
metabolic support provided by astrocytes [26]. These
quantitative parameters are heritable traits [27, 28],
thus genetic variation is another plausible reason for
the ethnic differential risk. Genome-wide association
studies (GWAS) in the African Caribbean population
of Barbados, which has a high prevalence of OAG
(6.8 %, 95 % CI 6.1–7.7 % in Blacks ≥40 years old)
[15], confirmed two mechanisms of gene interaction
with OAG: the absence of protective genes, and the
presence of predisposing alleles increased the risk for
OAG [29, 30]. Although the demographics of
Barbados have been dynamic, and there are other
socio-demographic and lifestyle factors that influence
disease incidence [31] and progression [12, 32], the
historical link between the Igbos and Barbadians
lends credence to the genetic basis for the ethnic dif-
ferences in risk of OAG seen in Nigeria.
Another interesting observation in our study was the
strong association between low BMI (underweight) and
OAG, albeit only in univariate analysis: presumably be-
cause of age, as older persons have lower BMI especially
when of poor socioeconomic status. Higher BMI has
been reported to be protective for OAG in Barbados
[12] and Rotterdam [33]. Systemic inflammatory process
[34] are possible linking factors which may also result in
weight loss from general debilitation.
Our study did not find significant difference in risk
for OAG in urban compared to rural population as
seen in urban South India where the prevalence of
OAG was more than doubled than in the rural popu-
lation [16]; and possible associations with hyperten-
sion or diabetes were not statistically significant.
All studies have shown increasing age to be a risk fac-
tor for OAG [12, 31, 32, 35–43]. Indeed, in the Barbados
Eye Study a 4 % increase in the relative risk of OAG
per year was reported [31], and comparable to 6 %
higher odds of OAG per year in this study. Increasing
mitochondrial dysfunction in retinal ganglion cells
and increased vulnerability of the optic nerve to
neurodegeneration from oxidative stress serve as pos-
sible links between ageing and increased risk for
OAG [44, 45].
This study also demonstrated that higher IOP has
an independent association with OAG, as in numer-
ous other studies. Higher IOP was an independent
risk factor for glaucoma despite a large number of
eyes having IOPs lower than the ‘upper limit of nor-
mal’ i.e. mean (+2SD) [40]. In the National Blindness
Survey, 56 % of glaucoma eyes had IOP <22 mmHg;
the mean IOP in glaucoma eyes was 23 (SD12)
mmHg and the mean IOP in non-glaucoma eyes was
14 (SD4) mmHg [9]. This underscores the role of
IOP as a tool for monitoring response to treatment
rather than as a diagnostic factor.
Men had higher odds of OAG but only in univariate
analysis. An increased risk of OAG in men has been
reported in previous prevalence studies in Barbados,
United States [12, 32] and Singapore [43], and in a
Bayesian meta-analysis, men were more likely to have
POAG than women (OR 1.36, 95 % CI 1.23–1.52) [1].
Further incidence studies are needed to clarify gender
differences in risks of OAG.
Some studies have addressed associations between
ocular perfusion factors (IOP, BP and MOPP) and OAG
which suggest that vascular insufficiency is an important
factor in OAG [31, 38, 46], as was in our study, higher
BP and lower MOPP were significantly associated with
higher odds of OAG.
Longer ocular axial length has been associated with
OAG [37, 47]. In the Nigeria Blindness Survey axial
length was longer in OAG eyes and was significantly
associated with OAG, but this was not an independ-
ent risk factor after adjusting for age, IOP and other
variables. In our study we assessed axial length rather
than myopia as a potential risk factor because there
was a high prevalence of nuclear lens opacities
(8.8 %, 95 % CI 7.5–10.1) [48] which would increase
Table 1 Distribution of participants with and without open-angle glaucoma by socio-demographic, biophysical and ocular
characteristics (Continued)
Ocular factorsb
Total eyes N = 26,316 (100 %) 25,634 (97.4 %) 682 (2.6 %)
Axial length (mm) Mean ± SD 22.63 ± 0.97 22.76 ± 1.09 p = 0.001
IOP (mmHg) Mean ± SD 14 ± 4 22 ± 11 p < 0.001
IOP intraocular pressure, OAG open-angle glaucoma, SD standard deviation
amissing values excluded; bocular factors distribution by eyes
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Table 2 Open-angle glaucoma and association with potential risk factors
All eyes OAG Univariate analysis Multivariate analysis
n (%) n (%) OR 95 % CI p-value OR 95 % CI p-value
26,316 (100 %) 682 (2.6 %)
Socio-demographic factors
Age (years) (Min 40) Reference Reference
Increasing age (Max 100) 1.06 1.06–1.07 <0.001 1.04 1.03–1.05 <0.001
Gender Female 328 (2.3) Reference Reference
Male 354 (2.9) 1.29 1.06–1.57 0.01 1.23 0.94–1.61 0.13
Ethnic group Hausa 113 (1.7) Reference Reference
Yoruba 150 (2.9) 1.71 1.24–2.36 0.001 1.10 0.75–1.63 0.62
Igbo 167 (4.5) 2.70 1.98–3.68 <0.001 1.73 1.18–2.56 0.01
Fulani 31 (1.9) 1.09 0.65–1.85 0.73 1.18 0.65–2.19 0.58
Kanuri 20 (2.9) 1.72 0.92–3.23 0.09 1.81 0.90–3.63 0.10
Tiv 15 (2.2) 1.30 0.64–2.62 0.47 1.03 0.42–2.52 0.96
Ijaw 14 (2.9) 1.69 0.86–3.35 0.13 1.51 0.50–4.60 0.47
Urhobo 7 (1.5) 0.85 0.32–2.23 0.74 0.69 0.24–1.97 0.48
Ibibio 10 (2.4) 1.43 0.62–3.27 0.40 1.29 0.58–2.89 0.53
Nupe 9 (2.2) 1.29 0.59–2.79 0.52 1.25 0.58–2.67 0.57
Others 144 (2.4) 1.38 1.01–1.90 0.05 1.13 0.75–1.70 0.57
Literacy Literate 235 (2.0) Reference Reference
Illiterate 447 (3.0) 1.50 1.22–1.84 <0.001 1.06 0.79–1.42 0.70
Place of residence Rural 527 (2.6) Reference Reference
Urban 155 (2.6) 1.02 0.81–1.28 0.88 1.14 0.85–1.54 0.38
Biophysical factors
Hypertension Normal 454 (2.4) Reference NI
Hypertension 223 (3.2) 1.38 1.12–1.70 0.002
Blood pressure Normal 454 (2.4) Reference Reference
(severity of stage 1 mild 110 (2.7) 1.15 0.88–1.51 0.31 0.87 0.57–1.33 0.52
hypertension) stage 2 moderate 68 (3.7) 1.61 1.16–2.24 0.01 1.05 0.58–1.90 0.87
stage 3 severe 45 (4.4) 1.91 1.27–2.88 0.002 1.05 0.45–2.45 0.90
Systolic BP (Min 60) Reference NI
(Max 259) 1.01 1.01–1.02 <0.001
Diastolic BP (Min 35) Reference NI
(Max 157) 1.01 1.00–1.02 0.002
RBGa Normal 141 (4.3) Reference NI
Diabetes 4 (4.1) 0.94 0.33–2.67 0.91
Body mass index Normal 406 (2.6) Reference Reference
(Categories) Underweight 116 (4.0) 1.60 1.21–2.10 0.001 1.29 0.91–1.83 0.16
Overweight 111 (2.2) 0.85 0.65–1.12 0.26 0.82 0.58–1.17 0.27
Obese 42 (1.9) 0.75 0.50–1.12 0.16 1.18 0.71–1.96 0.52
Ocular factors
Axial length (mm) (Min 18.4) Reference Reference
(Max 30.0) 1.14 1.03–1.26 0.01 0.99 0.89–1.10 0.88
I OP (mmHg) (Min 5) Reference Reference
(Max 50) 1.21 1.18–1.23 <0.001 1.22 1.18–1.25 <0.001
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the risk of index myopia; and a relatively low preva-
lence of myopia ≤0.5D (after excluding persons with
lens opacity, 9.4 %, 95 % CI 8.7–10.2) [49].
A strength of the Nigeria Blindness Survey is that it
was nationally representative and had a large sample
size with adequate power to detect statistical associa-
tions. A range of ethnic groups was represented in
large enough numbers to allow comparison of risk
between the largest ethnic groups in Nigeria. As part
of the study protocol, not all participants had gonio-
scopy done and we did not record the presence of
pseudoexfoliation (PXE). Hence, PXE was not
assessed as a risk factor for OAG. In addition, some
eligible participants did not have gonioscopy per-
formed due to damage to the mirrors on the gonio-
scopy lenses by high humidity; and did not have Van
Herick’s AC angle estimation due to structural ocular
pathology. Another limitation was that IOP was mea-
sured once and it was not interpreted using central
corneal thickness, which was not measured. Addition-
ally, visual field analysis was by FDT and participants
classified as glaucoma did not undergo Humphrey
visual field analysis (HFA). We were also not able to
obtain information on duration of hypertension,
history of cardiovascular disease or use of antihyper-
tensive medication. However, this may not have a sig-
nificant impact as only 14 % of participants reported
being hypertensive [18]. Additionally, we did not ob-
tain information on family history of glaucoma which
would not have been reliable in this context. Indeed,
only 5.6 % of those identified with OAG knew they
had the condition [9].
This is the first time that an association of OAG has
been observed with some ethnic groups. It is imperative
that this finding be replicated in further studies as it
may be a chance finding. While cultural or other prac-
tices might underlie the differences, or failure to fully
adjust for confounders, given the relative lack of envir-
onmental factors identified to date for OAG, these ob-
servations suggest the need for a molecular genetics
study of glaucoma in Nigeria. This might be included
within a follow-up study on the cohort of the Nigeria
Blindness Survey to explore the natural history and in-
cidence of glaucoma, and the influence of immuno-
logical markers of inflammation.
Conclusion
This study gives us risk factors data on OAG and con-
firms that OAG is a public health problem in people
≥40 years. As a public health strategy, opportunistic eye
examination, case detection and examination for OAG
need to be performed on all people aged ≥40 years and
the ethnic groups most at risk.
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